Skip to main content
Clinical Trials/NCT00776035
NCT00776035
Completed
Not Applicable

Sex and Obesity Effects on Myocardial Blood Flow and Metabolism

Washington University School of Medicine1 site in 1 country19 target enrollmentFebruary 1, 2000

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
Washington University School of Medicine
Enrollment
19
Locations
1
Primary Endpoint
Average Myocardial Blood Flow
Status
Completed
Last Updated
last year

Overview

Brief Summary

Sex has a major impact on myocardial metabolism and blood flow. In those without heart failure men's hearts tend to use proportionally more glucose and women's hearts use more fat and have higher blood flow.

Obesity is a major risk factor for Heart Failure. In those without heart failure, increasing body mass index is predictive of increased blood flow and fatty acid metabolism in women, but not men.

To measure blood flow and metabolism we used radioactive materials and a PET (positron emission Tomography) scan to study the blood flow and substrate metabolism of the heart.

Hypotheses: 1) Women with heart failure with reduced ejection fraction (HFrEF) will have higher levels of heart blood flow and fatty acid metabolism and lower glucose metabolism rates than men with HFrEF. A secondary Aim was to test the hypothesis that body mass index (BMI), a measure of obesity, correlated with myocardial blood flow and myocardial metabolism measures in patients with HFrEF.

Registry
clinicaltrials.gov
Start Date
February 1, 2000
End Date
April 2, 2011
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Average Myocardial Blood Flow

Time Frame: Study Day 2

Myocardial blood flow (MBF) was measured using \^15O-water injected intravenously intravenously through a large bore catheter into an antecubital vein during the (Positron Emission Tomography (PET) scan on Study Day 2.

Secondary Outcomes

  • Average Myocardial Fatty Acid Utilization(Study Day 2)

Study Sites (1)

Loading locations...

Similar Trials